BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32960876)

  • 1. Table: Correct Use of inhalers for COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e150-e154. PubMed ID: 32960876
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded table: Correct use of inhalers for asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):e204-e208. PubMed ID: 33446624
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):137-144. PubMed ID: 32960872
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison table: Inhaled long-acting bronchodilators for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e146-e147. PubMed ID: 32960874
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanded table: Some inhaled drugs for treatment of asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):e200-e203. PubMed ID: 33446623
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for asthma.
    Med Lett Drugs Ther; 2020 Dec; 62(1613):193-200. PubMed ID: 33446622
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison table: Inhaled corticosteroids for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e148-e149. PubMed ID: 32960875
    [No Abstract]   [Full Text] [Related]  

  • 8. Duaklir Pressair: another LAMA/LABA inhaler for COPD.
    Med Lett Drugs Ther; 2019 Sep; 61(1581):149-151. PubMed ID: 31599867
    [No Abstract]   [Full Text] [Related]  

  • 9. Trelegy Ellipta--a three-drug inhaler for COPD.
    Med Lett Drugs Ther; 2018 May; 60(1547):86-88. PubMed ID: 29913467
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison table: Inhaled short-acting bronchodilators for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e144-e145. PubMed ID: 32960873
    [No Abstract]   [Full Text] [Related]  

  • 11. Revefenacin (Yupelri) for COPD.
    Med Lett Drugs Ther; 2019 Jan; 61(1564):14-15. PubMed ID: 30856160
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.
    Kankaanranta H; Harju T; Kilpeläinen M; Mazur W; Lehto JT; Katajisto M; Peisa T; Meinander T; Lehtimäki L
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):291-307. PubMed ID: 25515181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
    Beeh KM; Derom E; Echave-Sustaeta J; Grönke L; Hamilton A; Zhai D; Bjermer L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():193-205. PubMed ID: 26893551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ▼Olodaterol--another LABA for COPD.
    Drug Ther Bull; 2015 Apr; 53(4):42-5. PubMed ID: 25858815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
    Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial.
    Ismaila AS; Birk R; Shah D; Zhang S; Brealey N; Risebrough NA; Tabberer M; Zhu CQ; Lipson DA
    Adv Ther; 2017 Sep; 34(9):2163-2172. PubMed ID: 28875459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dose comparison of Respimat
    Ciciliani AM; Langguth P; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
    Cramer JA; Bradley-Kennedy C; Scalera A
    Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium/olodaterol (Stiolto Respimat) for COPD.
    Med Lett Drugs Ther; 2015 Nov; 57(1482):161-2. PubMed ID: 26583607
    [No Abstract]   [Full Text] [Related]  

  • 20. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K
    Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.